Stoneridge Investment Partners »

Esperion Therapeutics shares owned by Stoneridge Investment Partners

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Stoneridge Investment Partners from 13F filings

Historical chart of Stoneridge Investment Partners investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Stoneridge Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Stoneridge Investment Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $87k 29k 2.97
2023-09-30 $29k 29k 0.99
2023-06-30 $41k 29k 1.40